| 标题 |
 【求助全文】【The Lancet Gastroenterology & Hepatology, 2025】Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial |
| 网址 | |
| DOI | |
| 其它 |
DOI: 10.1016/S2468-1253(25)00071-8 Title: Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial Journal: The Lancet Gastroenterology & Hepatology, 2025 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
张欢馨
woshi123
yjh123
22336
cdercder
昏睡的蟠桃
xing_xing
catank
v0id
高654866666322
挖掘机
丰富语蕊
Kao
Enigma_GEB
科研狗
Criminology34
aajhajkahna
pluto
乐空思
实验室
皖公网安备34019202002308
